Live
AgilentAgilent Taps Cirena To Turn Long RNA Technology Into Genome Editing Growth - Yahoo FinanceScience Daily BiotechScientists successfully transfer longevity gene and extend lifespanRecursionA Look At Recursion Pharmaceuticals (RXRX) Valuation After Recent Clinical And Cost Management Updates - simplywall.stSHINVA MEDICAL INSTRUMENT CO.,LTD.World Ampoule Filling And Sealing Machine - Market Analysis, Forecast, Size, Trends and Insights - IndexBox10x Genomics BlogWhy 10x Genomics (TXG) stock is down today - MSN10x Genomics NewsA Look At 10x Genomics (TXG) Valuation After Recent Share Price Moves - simplywall.st10x Genomics NewsA Look At 10x Genomics (TXG) Valuation After Recent Share Price Moves - simplywall.stSHINVA MEDICAL INSTRUMENT CO.,LTD.Stock List: Research Stocks from Around the World - GuruFocusMerck & Co.Merck & Co. Inc. stock (US58933Y1055): Earnings beat and pipeline update drive investor interest - AD HOC NEWSMettler ToledoMettler Toledo (MTD) Margin Slippage Tests Bullish Earnings Growth Narratives - simplywall.stLabCorpLabcorp stock (US50540R4092): Diagnostic and drug development leader in focus for US investors - AD HOC NEWSCellFerroptosis inhibition enhances liver and lung graft function
FierceBiotech Mar 26, 2026

Biopharma funding dropped 20% in 2025 as companies doubled down on big bets: IQVIA

Biopharma funding dropped 20% in 2025 as companies doubled down on big bets: IQVIA

Original
Body unavailable. Use the original source.